Please use this identifier to cite or link to this item:
http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/4943
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | SHANBHAG, KARTHIK | en_US |
dc.contributor.author | MHETRE, AMOL | en_US |
dc.contributor.author | KHANDELWAL, NEHA | en_US |
dc.contributor.author | KAMAT, SIDDHESH S. | en_US |
dc.date.accessioned | 2020-08-07T08:43:42Z | |
dc.date.available | 2020-08-07T08:43:42Z | |
dc.date.issued | 2020-09 | en_US |
dc.identifier.citation | Journal of Membrane Biology, 253, 381–397. | en_US |
dc.identifier.issn | 1432-1424 | en_US |
dc.identifier.issn | 0022-2631 | en_US |
dc.identifier.uri | http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/4943 | |
dc.identifier.uri | https://doi.org/10.1007/s00232-020-00133-2 | en_US |
dc.description.abstract | Lysophospholipids are potent hormone-like signalling biological lipids that regulate many important biological processes in mammals (including humans). Lysophosphatidic acid and sphingosine-1-phosphate represent the best studied examples for this lipid class, and their metabolic enzymes and/or cognate receptors are currently under clinical investigation for treatment of various neurological and autoimmune diseases in humans. Over the past two decades, the lysophsophatidylserines (lyso-PSs) have emerged as yet another biologically important lysophospholipid, and deregulation in its metabolism has been linked to various human pathophysiological conditions. Despite its recent emergence, an exhaustive review summarizing recent advances on lyso-PSs and the biological pathways that this bioactive lysophospholipid regulates has been lacking. To address this, here, we summarize studies that led to the discovery of lyso-PS as a potent signalling biomolecule, and discuss the structure, its detection in biological systems, and the biodistribution of this lysophospholipid in various mammalian systems. Further, we describe in detail the enzymatic pathways that are involved in the biosynthesis and degradation of this lipid and the putative lyso-PS receptors reported in the literature. Finally, we discuss the various biological pathways directly regulated by lyso-PSs in mammals and prospect new questions for this still emerging biomedically important signalling lysophospholipid. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer Nature | en_US |
dc.subject | Lysophosphatidylserine | en_US |
dc.subject | Lipases | en_US |
dc.subject | GPCR | en_US |
dc.subject | TLR2 | en_US |
dc.subject | Mast cell degranulation | en_US |
dc.subject | Macrophage efferocytosis | en_US |
dc.subject | TOC-AUG-2020 | en_US |
dc.subject | 2020 | en_US |
dc.subject | 2020-AUG-WEEK1 | en_US |
dc.title | The Lysophosphatidylserines—An Emerging Class of Signalling Lysophospholipids | en_US |
dc.type | Article | en_US |
dc.contributor.department | Dept. of Biology | en_US |
dc.identifier.sourcetitle | Journal of Membrane Biology | en_US |
dc.publication.originofpublisher | Foreign | en_US |
Appears in Collections: | JOURNAL ARTICLES |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.